Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

167 ta ish

Ish: CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy

  1. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

    Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht +9

    MaqolaOchiq kirish201213 iqtibos
    ABI

  2. The paths and challenges of “off-the-shelf” CAR-T cell therapy: An overview of clinical trials

    Vahid Moradi, Azadeh Omidkhoda, Naser Ahmadbeigi

    Sharh maqola20239 iqtibos
    ABI

  3. CAR-T cell therapy for cancer: current challenges and future directions

    Inés Zugasti, Lady Espinosa-Aroca, Klaudyna Fidyt +7

    Sharh maqola20259 iqtibos
    ABI

  4. Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review

    Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi +2

    Sharh maqola20248 iqtibos
    ABI

  5. Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies

    Xinyi Xiao, Shengkang Huang, Sifei Chen +4

    Sharh maqolaOchiq kirish20215 iqtibos
    ABI

  6. CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy

    Kaveh Hadiloo, Safa Tahmasebi, Abdolreza Esmaeilzadeh

    Sharh maqola20235 iqtibos
    ABI

  7. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

    Kazutoshi Takahashi, Koji Tanabe, Mari Ohnuki +4

    Maqola20074 iqtibos
    ABI

  8. Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects

    Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman +4

    Sharh maqola20244 iqtibos
    ABI

  9. Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy

    Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh +2

    Sharh maqola20254 iqtibos
    ABI

  10. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

    Junying Yu, Maxim A. Vodyanik, Kim Smuga-Otto +9

    Maqola20073 iqtibos
    ABI

  11. Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain Metastases

    Agata Kieliszek, Daniel Mobilio, Deepak Upreti +10

    Maqola20233 iqtibos
    ABI

  12. The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods

    Yekta Metanat, Patrik Viktor, Ayesha Amajd +10

    Sharh maqola20243 iqtibos
    ABI

  13. CD19.CAR T-cell–derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy

    Paola Lanuti, Francesco Guardalupi, Giulia Corradi +32

    Maqola20253 iqtibos
    ABI

  14. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors

    Kazutoshi Takahashi, Shinya Yamanaka

    MaqolaOchiq kirish20062 iqtibos
    ABI

  15. Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins

    Hongyan Zhou, Shili Wu, Jin Young Joo +11

    MaqolaOchiq kirish20092 iqtibos
    ABI

  16. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells

    Amélie Montel‐Hagen, Christopher S. Seet, Suwen Li +11

    Maqola20192 iqtibos
    ABI

  17. A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy

    Shoichi Iriguchi, Yutaka Yasui, Yohei Kawai +17

    Maqola20212 iqtibos
    ABI

  18. CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>

    Karlo Perica, Nayan Jain, Michael Scordo +23

    Maqola20252 iqtibos
    ABI

  19. Harnessing the potential of gene-editing technology to overcome the current bottlenecks of CAR-T cell therapy in T-cell malignancies

    Ahmed Ismail, Mohsen A. Khormi, Wedad Mawkili +6

    Sharh maqola20252 iqtibos
    ABI

  20. Applications of nanoparticles in CAR-T cell therapy: non-viral manufacturing, enhancing in vivo function, and in vivo generation of CAR-T cells

    Yasmeen A. Albalawi

    Sharh maqola20252 iqtibos
    ABI

  21. Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review

    Chaozhi Tang, Yuling Zhang

    Sharh maqola20242 iqtibos
    ABI

  22. Designs of NKG2D-based immunotherapeutics for cancer

    Jianfeng Han, Youwei Wang, Gcf Chan +1

    Sharh maqola20252 iqtibos
    ABI

  23. Understanding the role of neutrophils in acute respiratory distress syndrome

    Shun-Chin Yang, Yung-Fong Tsai, Yen-Lin Pan +1

    Sharh maqola20202 iqtibos
    ABI

  24. Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products

    Muhammad Sadeqi Nezhad, Meghdad Abdollahpour‐Alitappeh, Behzad Rezaei +2

    Sharh maqola20212 iqtibos
    ABI

  25. Addressing graft-versus-host disease in allogeneic cell-based immunotherapy for cancer

    Zibai Lyu, Siyue Niu, Ying Fang +3

    Sharh maqola20252 iqtibos
    ABI